The University of Edinburgh
Multi omics-analysis and compounds supplementation identifies B. subtilis produced metabolites that reduce α-synuclein aggregation in C. elegans
Abstract
dc:description.abstractThe aggregation of α-synuclein is a pathological hallmark of Parkinson’s disease. In this study, we used the nematode Caenorhabditis elegans as a model to investigate the potential mechanisms via which the bacterium Bacillus subtilis protects against α-synuclein aggregation. Previous findings from our lab showed that feeding C. elegans with B. subtilis significantly reduces α-synuclein aggregation compared to the standard laboratory diet Escherichia coli OP50. A genetic screen in B. subtilis revealed that deletion of specific genes involved in central metabolism pathways abolished this protective effect, suggesting that bacterial compounds produced by these pathways play a key role in modulating aggregation. This study aimed to identify the metabolites responsible for this protective effect, assess whether their activity requires metabolically active bacteria, and clarify the mechanism underlying the protective effects of B. subtilis on host. I integrated metabolomics and transcriptomics to identify candidate metabolites that were significantly downregulated in non-protective mutants, then tested their ability to rescue the aggregation phenotype by supplementing them into worm growth media. To determine whether live bacteria were necessary for protection, supplementation assays were also conducted with inactivated B. subtilis. In parallel, proteomic analysis was performed to examine host molecular responses. Combination of transcriptomics and metabolomics identified 33 downregulated metabolites as candidates, many of which are linked to the branched-chain amino acid and bacilysocin biosynthesis pathway. Supplementation with selected metabolites including 12-methyltetradecanoic acid, 2-oxobutyric acid, AMP, asparagine, and fumarate significantly rescued aggregation phenotypes. The protective effect of some metabolites, such as 12-methyltetradecanoic acid and 2-oxobutyric acid, was independent of bacterial activity, suggesting a direct action on the host. Proteomics revealed that protective strains primarily promote host proteolysis and strengthen cellular barriers to facilitate aggregate clearance. In conclusion, this study identifies B. subtilis metabolites that mediate the protective effect and elucidates their mechanism of action. These findings contribute to a deeper understanding of gut microbe–host interactions in neurodegenerative disease.
Degree
thesis:*- Grantor dc:publisher
- The University of Edinburgh
- Year dc:date.issued
- 2025
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Guan, Jiaxi
- Advisors dc:contributor.advisor
-
- Doitsidou, Maria
- Prakash, Deep
Subjects
dc:subject × 7Rights
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Identifier URI
- http://dx.doi.org/10.7488/era/6779